$KGNR
AMJ Global Technology

2020 Q4 Form 10-K Financial Statement

#000147793221006333 Filed on September 15, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.200K
YoY Change -98.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.200K
YoY Change -98.59%
Operating Profit -$1.200K
YoY Change -98.59%
Interest Expense $10.30K
YoY Change
% of Operating Profit
Other Income/Expense, Net $10.30K
YoY Change -101.95%
Pretax Income $9.100K
YoY Change -101.49%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $9.098K
YoY Change -101.49%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $625.30
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $16.55K $16.55K
YoY Change -100.0% 164.79% 164.8%
Cash & Equivalents $0.00 $0.00
Short-Term Investments $0.00 $16.55K $16.55K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $0.00 $16.55K $16.55K
YoY Change -100.0% 164.79% 164.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $16.55K $16.55K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $16.55K $16.55K
YoY Change -100.0% 164.79% 164.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.900K
YoY Change 21.05%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $13.78K
YoY Change 138.41%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.78K $20.68K $20.68K
YoY Change 5.32% 6.16% 6.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $21.78K $20.68K $20.68K
Total Long-Term Liabilities $0.00
Total Liabilities $20.68K
YoY Change 6.16%
SHAREHOLDERS EQUITY
Retained Earnings -$1.312M -$1.311M
YoY Change 0.08% -0.69%
Common Stock $14.40K $14.55K
YoY Change -1.08% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$21.78K -$4.129K -$4.130K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $16.55K $16.55K
YoY Change -100.0% 164.79% 164.8%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019
OPERATING ACTIVITIES
Net Income $9.098K
YoY Change -101.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities $0.00
Cash From Investing Activities
Cash From Financing Activities $0.00
Net Change In Cash $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14396323 shares
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
0 USD
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
16547 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
16547 USD
CY2020Q4 us-gaap Assets
Assets
0 USD
CY2019Q4 us-gaap Assets
Assets
16547 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5500 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6900 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
16276 USD
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
13776 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21776 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20676 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14396323 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14553465 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
14396 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
14553 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1276084 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1292474 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1312256 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1311156 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-4129 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16547 USD
CY2020 us-gaap Revenues
Revenues
0 USD
CY2019 us-gaap Revenues
Revenues
0 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1100 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1200 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
1100 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
1200 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1100 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-1200 USD
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
10298 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10298 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
9098 USD
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14414405 shares
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14553465 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-13227 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
9098 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-4129 USD
CY2020 kgnr Common Shares Cancelled Amount
CommonSharesCancelledAmount
-16547 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-1100 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21776 USD
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
10298 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1400 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2500 USD
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1200 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
2500 USD
CY2019 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
0 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2500 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020 kgnr Common Shares Cancelled For Return Of Equity Investment
CommonSharesCancelledForReturnOfEquityInvestment
16547 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2500 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1312256 USD
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments. </p>
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14396323 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14553465 shares
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2017Q4 kgnr Exchange Common Stock Value
ExchangeCommonStockValue
81000 USD
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-231 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1911 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
231 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1911 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
155054 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
154823 USD
CY2020Q4 kgnr Deferred Tax Asset Valuation Allowances
DeferredTaxAssetValuationAllowances
-155054 USD
CY2019Q4 kgnr Deferred Tax Asset Valuation Allowances
DeferredTaxAssetValuationAllowances
-154823 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2020Q4 kgnr Deferred Tax Asset Valuation Allowance
DeferredTaxAssetValuationAllowance
155054 USD
CY2019Q4 kgnr Deferred Tax Asset Valuation Allowance
DeferredTaxAssetValuationAllowance
154823 USD

Files In Submission

Name View Source Status
0001477932-21-006333-index-headers.html Edgar Link pending
0001477932-21-006333-index.html Edgar Link pending
0001477932-21-006333.txt Edgar Link pending
0001477932-21-006333-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kgnr-20201130.xsd Edgar Link pending
kgnr-20201130_cal.xml Edgar Link unprocessable
kgnr-20201130_def.xml Edgar Link unprocessable
kgnr-20201130_lab.xml Edgar Link unprocessable
kgnr-20201130_pre.xml Edgar Link unprocessable
kgnr_10k.htm Edgar Link pending
kgnr_10k_htm.xml Edgar Link completed
kgnr_ex311.htm Edgar Link pending
kgnr_ex312.htm Edgar Link pending
kgnr_ex321.htm Edgar Link pending
kgnr_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending